Georgia-Pacific Corporation, Plaintiff-Cross v. United States Gypsum Company and L&w Supply Corporation

195 F.3d 1322, 52 U.S.P.Q. 2d (BNA) 1590, 1999 U.S. App. LEXIS 28150
CourtCourt of Appeals for the Federal Circuit
DecidedNovember 1, 1999
Docket97-1238, 97-1244
StatusPublished
Cited by105 cases

This text of 195 F.3d 1322 (Georgia-Pacific Corporation, Plaintiff-Cross v. United States Gypsum Company and L&w Supply Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Georgia-Pacific Corporation, Plaintiff-Cross v. United States Gypsum Company and L&w Supply Corporation, 195 F.3d 1322, 52 U.S.P.Q. 2d (BNA) 1590, 1999 U.S. App. LEXIS 28150 (Fed. Cir. 1999).

Opinion

DECISION

PER CURIAM.

United States Gypsum Company and L W Supply Corporation (USG) appeal the judgment of the United States District Court for the District of Delaware holding that USG infringed claims 1, 2, and 5 of U.S. Patent No. 4,647,496 (the 496 patent) and claims 1, 6, 9,10, 12,15, and 17 of U.S. Patent No. 5,371,989 (the 989 patent), both patents being owned by Georgia-Pacific Corporation (Georgia-Pacific). In addition, USG appeals the district courts denial of its motion for judgment as a matter of law (JMOL) that all of the asserted claims are invalid due to obviousness in light of the prior art and that the asserted claims of the 989 patent are invalid for obviousness-type double patenting over the 496 patent and U.S. Patent No. 4,810,569 (the 569 patent). 1 USG also appeals the order of the district court granting a new trial rather than granting USGs post trial motion for JMOL with respect to infringement of claim 11 of the 496 patent, claim 8 of the 989 patent and claim 1 and 2 of U.S. Patent No. 5,319,900 (the 900 patent), also owned by Georgia-Pacific. Georgia-Pacific cross appeals the district courts failure to find USGs infringement of Georgia-Pacifics patents willful and its order granting a new trial to USG with respect to infringement of claim 11 of the 496 patent, claim 8 of the 989 patent, and claims 1 and 2 of the 900 patent. We affirm-in-part, reverse-in-part, vacate-in-part and remand.

BACKGROUND

The patents at issue relate to fiberglass 2 mat-reinforced gypsum boards and the use of such boards in exterior insulation systems (ElSystems).

Gypsum wallboard traditionally consists of a hardened gypsum core sandwiched *1325 between paper facing or similar reinforcing sheets. It is typically manufactured on a conveyor system. The gypsum is crushed and ground and mixed with water to form a core slurry. The core slurry is spread onto a first sheet of paper. A second sheet of paper is placed on top of the wet slurry. This combination is passed under a roller to achieve the desired thickness. After the core gypsum sets or hardens, the board is cut and then turned over and dried in a kiln.

Exterior gypsum wallboard, sometimes referred to as sheathing, is a component in an EISystem. The gypsum sheathing is attached to a frame of a house. Despite the use of water-resistant additives as well as water-repellent facings gypsum sheathing continued to be susceptible to degradation by water. If the paper faced gypsum board became wet, the paper facing would often peel away from the gypsum core.

The use of fiberglass mats instead of paper mats was known to solve peeling. The manufacture of a fiberglass gypsum board on the same production line used for the manufacture of traditional paper faced gypsum board remained a problem. Fiberglass matting, being more porous than paper matting, allowed the gypsum slurry to bleed through and foul the production line and, particularly, the rollers. Although the production line could be stopped to clean the gypsum buildup off the manufacturing rollers, some of the rollers, such as those in or near the kiln, were not easily accessible for such clean up.

Georgia-Pacific realized that the problem of the gypsum slurry bleeding through the fiberglass could be solved by controlling the viscosity of the slurry. Georgia-Pacific patented this invention as well as the use of such a fiberglass faced gypsum board in an EISystem in the patents at issue.

The 496 patent contains claims directed to an EISystem installed using glass mat faced gypsum boards. The jury found that USG infringed claims 1, 2, 5, and 11 of the 496 patent. The jurys verdict was sustained by the district court, except for claim 11. The court held that Georgia-Pacific had not adduced substantial evidence to support an infringement verdict as to claim 11 and granted USG a new trial.

The jury found that USG infringed asserted claims 1 and 2 of the 900 patent. This patent is directed to a fiberglass mat-reinforced gypsum board which contains fire and water-resistant additives. The district court held that the evidence did not support infringement of these two claims and granted USG a new trial.

The final patent on appeal, the 989 patent, contains claims directed to both fiberglass mat-reinforced gypsum boards and ElSystems using such boards. Each of the asserted claims 1, 6, 8, 9,10,12,15 and 17 was found by the jury to be infringed by USG. In this case the district court sustained the infringement verdict as to all claims except claim 8. This claim required the use of certain fire-resistant additives. Like its holding as to claims 1 and 2 of the 900 patent the court found there was not substantial evidence to support infringement and granted USG a new trial.

The parties have dealt with the claims under five categories; namely, sandwiched claims, faced claims, system claims, additive claims and board claims. The sandwiched claims, whether describing the board or the use of the board in an EISys-tem, contain the limitation that the gypsum core is sandwiched between two sheets of porous fiberglass mat. The faced claims all have the limitation that the gypsum board be faced with a fibrous mat, or that it be glass-mat faced. The system claims relate to the use of fiberglass mat-reinforced gypsum boards as the substrate for layered systems used to finish the exterior portions of buildings. The additive claims contain the limitation that the claimed fiberglass mat-reinforced gypsum board contain additives which improve the fire and/or water-resistant properties of the boards. Finally the board claims all claim a fiberglass mat-reinforced gypsum *1326 board (which in some cases contains fire or water-resistant additives).

DISCUSSION

I. Obviousness-Type Double Patenting

USG contends that the 989 patent, which issued more that five years after the 569 patent, was invalid for obviousness-type double patenting over the claims of the 496 and 569 patents. Georgia-Pacific, however, asserts that there are patentable distinctions between the claims of these patents, and that USG presented no competent evidence in support of its contention. The district court did not dwell on this issue, and merely dismissed it (along with certain other contentions of USG in its motion for JMOL) by stating that it had reviewed them and finds them to be without merit.

Double patenting is a question of law, which we review de novo. See General Foods Corp. v. Studiengesellschafi Kohle, 972 F.2d 1272, 1277, 23 USPQ2d 1839, 1843 (Fed.Cir.1992). De novo review is appropriate because double patenting is a matter of what is claimed, and therefore is treated like claim construction upon appellate review. See id. at 1277, 23 USPQ2d at 1843. Obviousness-type double patenting is a judicially created doctrine grounded in public policy, which prevents the extension of the term of the original' patent via the patenting of an obvious variation. See In re Longi, 759 F.2d 887

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Halozyme, Inc. v. Iancu
320 F. Supp. 3d 788 (E.D. Virginia, 2018)
Forest Laboratories, LLC v. Sigmapharm Laboratories, LLC
257 F. Supp. 3d 664 (D. Delaware, 2017)
Shire Development, LLC v. Watson Pharmaceuticals, Inc.
848 F.3d 981 (Federal Circuit, 2017)
Clare v. Chrysler Group LLC
819 F.3d 1323 (Federal Circuit, 2016)
Inre: Hitachi Metals, Ltd.
603 F. App'x 976 (Federal Circuit, 2015)
Parker-Hannifin Corp. v. Baldwin Filters, Inc.
724 F. Supp. 2d 810 (N.D. Ohio, 2010)
Smith & Nephew, Inc. v. Arthrex, Inc.
355 F. App'x 384 (Federal Circuit, 2009)
Amgen Inc. v. F. Hoffmann-La Roche Ltd.
580 F.3d 1340 (Federal Circuit, 2009)
Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.
566 F.3d 989 (Federal Circuit, 2009)
Abbott Laboratories v. Sandoz, Inc.
544 F.3d 1341 (Federal Circuit, 2008)
AMERICAN MEDICAL SYSTEMS, INC. v. Biolitec, Inc.
569 F. Supp. 2d 313 (D. Massachusetts, 2008)
Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc.
518 F.3d 1353 (Federal Circuit, 2008)
Cordis Corp. v. Medtronic Ave, Inc.
511 F.3d 1157 (Federal Circuit, 2008)
Laboratoires Perouse v. W.L. Gore & Associates, Inc.
528 F. Supp. 2d 362 (S.D. New York, 2007)
Cias, Inc. v. Alliance Gaming Corp.
504 F.3d 1356 (Federal Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
195 F.3d 1322, 52 U.S.P.Q. 2d (BNA) 1590, 1999 U.S. App. LEXIS 28150, Counsel Stack Legal Research, https://law.counselstack.com/opinion/georgia-pacific-corporation-plaintiff-cross-v-united-states-gypsum-cafc-1999.